SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-005785
Filing Date
2020-01-31
Accepted
2020-01-31 16:50:00
Documents
1
Period of Report
2020-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3307
  Complete submission text file 0001209191-20-005785.txt   4841
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HELICOS BIOSCIENCES CORPORATION 1 KENDALL SQUARE, BUILDING 700 CAMBRIDGE MA 02139
Business Address
Lafond Kevin G (Reporting) CIK: 0001429559 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 20565686